News

News

Exclusive interview: A new generation of senolytic

Exclusive interview: A new generation of senolytic

When is a drug not a drug? When it’s a NaNot. Interesting new technology that’s already on its way through FDA and targeting $40m Series B after current bridge.

NaNotics promises a new kind of medication

NaNotics promises a new kind of medication

In another breakthrough for nanotech, one company says it has found a way to combat age related diseases.